A systematic analysis of methylene blue for drug-induced shock

References

• Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–1734.
   PubMed Web of Science ®Google Scholar
• Mowry JB, Spyker DA, Brooks DE, et al. 2014 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015;53:962–1147.
   PubMed Web of Science ®Google Scholar
• Andresen M, Dougnac A, Díaz O, et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care. 1998;13:164–168.
   PubMed Web of Science ®Google Scholar
• Evora PR, Oliveira-Neto AM, Duarte NM, et al. Methylene blue as treatment for contrast medium-induced anaphylaxis. J Postgrad Med. 2002;48:327.
   PubMedGoogle Scholar
• Cochrane Haematological Malignancies Group. How to develop a search strategy for a Cochrane Review; [cited 2015 Aug 10] 2007. Available from: http://chmg-old.cochrane.org/sites/chmg-old.cochrane.org/files/uploads/How%20to%20develop%20a%20search%20strategy-support-manual.pdf.
   Google Scholar
• OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford center for evidence-based-medicine. [cited 2016 Jan 12]. Available from: http://www.cebm.net/index.aspx?o=5653.
   Google Scholar
• Jang DH, Nelson LS, Hoffman RS. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med. 2011;58:565–567.
   PubMed Web of Science ®Google Scholar
• Kim HK, Hoffman RS, Nelson LS, et al. Methylene blue for refractory hypotension in cardiovascular drug overdose [abstract]. Clin Toxicol. 2012;50:365.
   Web of Science ®Google Scholar
• Kalimullah E, Lee S, Nelson D. Diltiazem levels after overdose in the setting of multiorgan failure and extracorporeal support Frazee [abstract]. Crit Care Med. 2013;41:A338.
   Google Scholar
• Aggarwal N, Kupfer Y, Seneviratne C, et al. Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose. BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007402.
   Google Scholar
• Jordanhazy RA, Swartzentruber GS, Yanta JH, et al. Case series of fatal calcium channel blocker overdoses treated with veno-arterial extracorporeal membrane oxygenation for refractory hypotension and shock [abstract]. Clin Toxicol. 2014;52:772.
   Web of Science ®Google Scholar
• Laes JR, Williams DM, Katzung KG, et al. Hemodialysis complications after intravenous fat emulsion administration [abstract]. Clin Toxicol. 2014;52:754.
   Web of Science ®Google Scholar
• Kazim S, Chuang R, Dias V, et al. Treatment of massive verapamil overdose with peripheral veno-arterial extracorporeal membrane oxygenation [abstract]. Clin Toxicol. 2014;52:765.
   Web of Science ®Google Scholar
• Weinberg RL, Bouchard NC, Abrams DC, et al. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion. 2014;29:53–56.
   PubMed Web of Science ®Google Scholar
• Gérard L, Galloy AC, Capron A, et al. Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS). Clin Toxicol. 2015;53:573–577.
   Web of Science ®Google Scholar
• Livshits Z, Nelson LS, Hernandez SH, et al. Severe metformin toxicity: role of methylene blue and CVVHD as therapeutic adjuncts [abstract]. Clin Toxicol. 2010;48:611–612.
   Web of Science ®Google Scholar
• Plumb B, Parker A, Wong P. Feeling blue with metformin-associated lactic acidosis. BMJ Case Rep. 2013. doi:10.1136/bcr-2013-008855.
   PubMedGoogle Scholar
• Höjer J, Westerbergh J, Edfeldt-Ugarph M, et al. Metylenblåu hävde metformin associerad laktacidos. [Methylene blue stopped metformin-associated lactic acidosis.]. Läkartidningen. 2013;110:1865–1866.
   PubMedGoogle Scholar
• Westerbergh J, Höjer J. Metformin-induced refractory vasodilatory shock successfully treated with methylene blue [abstract]. Clin Toxicol. 2013;51:364.
   Web of Science ®Google Scholar
• Heredia D, Mancl E, Sayegh B, et al. Successful use of methylene blue for hemodynamically unstable metformin toxicity [abstract]. Chest. 2014;146:253A.
   Google Scholar
• Graham RE, Cartner M, Winearls J. A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy. BMJ Case Rep. 2015. doi:s10.1136/bcr-2015-210229.
   Google Scholar
• Fisher J, Taori G, Braitberg G, et al. Methylene blue used in the treatment of refractory shock resulting from drug poisoning. Clin Toxicol (Phila). 2014;52:63–65.
   PubMed Web of Science ®Google Scholar
• Curry SC, Levine M, French R, et al. Cardiovascular collapse and shock following ibuprofen ingestion [abstract]. Clin Toxicol. 2011;49:616.
   Web of Science ®Google Scholar
• French D, Smollin C, Ruan W, et al. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol. 2011;49:801–809.
   PubMed Web of Science ®Google Scholar
• Baselt RC. Disposition of toxic drugs and chemicals in man. Seal Beach: Biomedical Publications; 2014:1312–1313.
   Google Scholar
• National Center for Biotechnology Information. Pubchem compound database; CID =6099; 2005. [cited 2016 Apr 1]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/6099.
   Google Scholar
• Ding Y, Vaziri ND. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension. 1998;32:718–723.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;97:576–580.
   PubMed Web of Science ®Google Scholar
• Davis BJ, Xie Z, Viollet B, et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes. 2006;55:496–505.
   PubMed Web of Science ®Google Scholar
• Juffermans NP, Vervloet MG, Daemen-Gubbels CR, et al. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. Nitric Oxide. 2010;22:275–280.
   PubMed Web of Science ®Google Scholar
• Sonobe T, Haouzi P. H2S induced coma and cardiogenic shock in the rat: effects of phenothiazinium chromophores. Clin Toxicol (Phila). 2015;53:525–539.
   PubMed Web of Science ®Google Scholar
• Jang DH, Donovan S, Nelson LS, et al. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock. Ann Emerg Med. 2014;65:410–415.
   PubMed Web of Science ®Google Scholar
• Blass N, Fung D. Dyed but not dead-methylene blue overdose. Anesthesiology. 1976;45:458–459.
   PubMed Web of Science ®Google Scholar
• Gourlain H, Buneaux F, Borron SW, et al. Interference of methylene blue with co-oximetry of hemoglobin derivatives. Clin Chem. 1997;43:1078–1080.
   PubMed Web of Science ®Google Scholar
• Bach KK, Lindsay FW, Berg LS, et al. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesth Analg. 2004;99:1573–1574.
   PubMed Web of Science ®Google Scholar
• Kartha SS, Chacko CE, Bumpous JM, et al. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg. 2006;135:765–768.
   PubMed Web of Science ®Google Scholar
• Sweet G, Standiford SB. Methylene-blue-associated encephalopathy. J Am Coll Surg. 2007;204:454–458.
   PubMed Web of Science ®Google Scholar
• FDA Drug Safety Communication. Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications; [cited 2015 Nov 6]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm.
   Google Scholar
• Birch AA, Boyce WH. Hypertension and decreased renal blood flow following methylene blue injection. Anesth Analg. 1976;55:674–676.
   PubMed Web of Science ®Google Scholar
• Khanduri U, Sharma A, Kumar P. Unique red cell abnormality in a case of fatal methylene blue induced haemolysis. Hematology. 2004;9:239–241.
   PubMedGoogle Scholar